FUREN Group Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 1,339.624 million compared to CNY 2,768.963 million a year ago. Operating income was CNY 95.273 million compared to CNY 511.639 million a year ago. Net income was CNY 68.116 million compared to CNY 399.002 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.64 a year ago.